Credit: mannKind. Furoscix ReadyFlow offers a rapid, outpatient alternative for acute fluid overload management in heart failure and chronic kidney disease. Furoscix ReadyFlow demonstrated a ...
The oral RAS(ON) multi-selective inhibitor nearly doubled overall survival compared with investigator’s choice chemotherapy in the phase 3 RASolute 302 trial.
Retatrutide 12mg achieved up to 22.6% (55.8 lbs) mean weight loss at week 80, alongside marked improvements in ...
Lundbeck’s investigational oral orexin 2 receptor agonist gains Fast Track status, aiming to address underlying pathophysiology in patients with narcolepsy.
The analysis included 75 brick-and-mortar weight-loss clinics and medical spas offering compounded GLP-1 RAs. HealthDay News — Despite the end of nationwide shortages of glucagon-like peptide-1 ...
One in about 7300 individuals in the general population have PMS, a rare genetic condition that causes medical, intellectual, and behavioral challenges.
In a scientific statement, the association states that consuming caffeinated coffee linked to reduced risks for type 2 diabetes, heart disease, stroke, heart failure.
For patients aged 4 to 66 years with acquired hypothalamic obesity, setmelanotide leads to significantly greater reductions ...
Jideytro is FDA-approved for adult patients with locally advanced or metastatic ROS1-positive NSCLC who received prior ROS1 TKI therapy.
Cherry angiomas (CAs), also known as Campbell de Morgan spots, are common, benign, well-demarcated cutaneous vascular ...
In the CALIBRATE trial, 76% of encaleret-treated patients normalized both blood and urine calcium at week 24 vs 4% on standard of care, while 91% achieved intact PTH restoration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results